1,4-Bis((3,4-dimethoxyphenyl)sulfonyl)-1,4-diazepane, 98%, 100mg

Solución de formaldehído al 30 %, bajo contenido de metanol, 5 l

ORLISTAT, 95%, 1g

Bis(8-quinolinolato)copper(II) (purified by sublimation)>98.0%(T)1g

2-Chloro-1-(6-fluoro-1H-indol-3-yl)-ethanone, 98.0%, 50mg

4-(4-Methylpiperazin-1-yl)pyridin-3-amine, 100mg

Methyl 6-iodonicotinate, 95.0%, 250mg

2-BROMO-1-(DIFLUOROMETHOXY)-4-FLUOROBENZENE, 95.0%, 100mg

BIS[4-(4-AMINOPHENOXY)PHENYL]SULFONE, 95%, 25g

N-(17-Hydroxy-3,6,9,12,15-pentaoxaheptadecyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 1g

((2,5-dimethylphenyl)sulfonyl)alanine, 95.0%, 1g

(R)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid, potassium salt, 98%, 100mg

1,4-Benzoquinone>97.0%(T)500g